These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11731432)

  • 1. Antisense oligodeoxynucleotide targeted to Midkine, a heparin-binding growth factor, suppresses tumorigenicity of mouse rectal carcinoma cells.
    Takei Y; Kadomatsu K; Matsuo S; Itoh H; Nakazawa K; Kubota S; Muramatsu T
    Cancer Res; 2001 Dec; 61(23):8486-91. PubMed ID: 11731432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotide Elk-1 suppresses the tumorigenicity of human hepatocellular carcinoma cells.
    Ying TH; Hsieh YH; Hsieh YS; Liu JY
    Cell Biol Int; 2008 Feb; 32(2):210-6. PubMed ID: 17950002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of EGFR antisense oligodeoxynucleotide on human hepatoma cell line.
    Gong ZB; Liu JM; Li YM
    Hepatobiliary Pancreat Dis Int; 2005 Aug; 4(3):433-6. PubMed ID: 16109531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Telomerase antisense inhibition and chemotherapeutic combination treatments for the proliferation of endometrial cancer in vitro and in vivo].
    Chen XJ; Zheng W; Chen LL; Chen ZB; Wang SQ
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(20):1721-5. PubMed ID: 15569435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of sequence and phosphorothioate content to inhibition of cell growth and adhesion caused by c-myc antisense oligomers.
    Chavany C; Connell Y; Neckers L
    Mol Pharmacol; 1995 Oct; 48(4):738-46. PubMed ID: 7476902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midkine and LDL-receptor-related protein 1 contribute to the anchorage-independent cell growth of cancer cells.
    Chen S; Bu G; Takei Y; Sakamoto K; Ikematsu S; Muramatsu T; Kadomatsu K
    J Cell Sci; 2007 Nov; 120(Pt 22):4009-15. PubMed ID: 17971413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5'-,3'-inverted thymidine-modified antisense oligodeoxynucleotide targeting midkine. Its design and application for cancer therapy.
    Takei Y; Kadomatsu K; Itoh H; Sato W; Nakazawa K; Kubota S; Muramatsu T
    J Biol Chem; 2002 Jun; 277(26):23800-6. PubMed ID: 11959856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice.
    Aharinejad S; Abraham D; Paulus P; Abri H; Hofmann M; Grossschmidt K; Schäfer R; Stanley ER; Hofbauer R
    Cancer Res; 2002 Sep; 62(18):5317-24. PubMed ID: 12235002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of glioblastoma U-87 by systemic administration of an antisense protein kinase C-alpha phosphorothioate oligodeoxynucleotide.
    Yazaki T; Ahmad S; Chahlavi A; Zylber-Katz E; Dean NM; Rabkin SD; Martuza RL; Glazer RI
    Mol Pharmacol; 1996 Aug; 50(2):236-42. PubMed ID: 8700129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antisense oligodeoxynucleotide against HST-1/FGF-4 suppresses tumorigenicity of an orthotopic model for human germ cell tumor in nude mice.
    Hirai K; Sasaki H; Sakamoto H; Takeshita F; Asano K; Kubota Y; Ochiya T; Terada M
    J Gene Med; 2003 Nov; 5(11):951-7. PubMed ID: 14601132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides.
    Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y
    J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
    Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
    Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of MDR1 phosphorothioate antisense oligodeoxynucleotides in multidrug-resistant human tumor cell lines and xenografts.
    Ramachandran C; Wellham LL
    Anticancer Res; 2003; 23(3B):2681-90. PubMed ID: 12894558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibition effects of c-erbB-2 and c-raf-1 antisense oligodeoxynucleotides combined transfection on the human ovarian carcinoma transplanted subcutaneously in nude mice].
    Wu YZ; Ren QL; Yang SF; Chen XP; Li SL
    Zhonghua Fu Chan Ke Za Zhi; 2003 Jun; 38(6):359-61. PubMed ID: 12895380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human antisense-vascular endothelial growth factor gene therapy for laryngeal tumor by cationic liposome-mediated transfection].
    Deng ZH; Jin M; Huang WG; Qiu JH; Liu SL; Wang JL
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 39(1):8-12. PubMed ID: 15127560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of CRIPTO expression and tumorigenicity in human colon cancer cells by antisense RNA and oligodeoxynucleotides.
    Ciardiello F; Tortora G; Bianco C; Selvam MP; Basolo F; Fontanini G; Pacifico F; Normanno N; Brandt R; Persico MG
    Oncogene; 1994 Jan; 9(1):291-8. PubMed ID: 8302592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new family of heparin-binding growth/differentiation factors: increased midkine expression in Wilms' tumor and other human carcinomas.
    Tsutsui J; Kadomatsu K; Matsubara S; Nakagawara A; Hamanoue M; Takao S; Shimazu H; Ohi Y; Muramatsu T
    Cancer Res; 1993 Mar; 53(6):1281-5. PubMed ID: 8383007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells.
    Kishima Y; Yoshida K; Enomoto H; Yamamoto M; Kuroda T; Okuda Y; Uyama H; Nakamura H
    Hepatogastroenterology; 2002; 49(48):1639-44. PubMed ID: 12397753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG immunomer DNA enhances antisense protein kinase A RIalpha inhibition of multidrug-resistant colon carcinoma growth in nude mice: molecular basis for combinatorial therapy.
    Nesterova MV; Johnson NR; Stewart T; Abrams S; Cho-Chung YS
    Clin Cancer Res; 2005 Aug; 11(16):5950-5. PubMed ID: 16115938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer].
    Liu JP; Yuan SZ; Zhang SN
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.